191 related articles for article (PubMed ID: 22363817)
1. Matrix-bound PAI-1 supports cell blebbing via RhoA/ROCK1 signaling.
Cartier-Michaud A; Malo M; Charrière-Bertrand C; Gadea G; Anguille C; Supiramaniam A; Lesne A; Delaplace F; Hutzler G; Roux P; Lawrence DA; Barlovatz-Meimon G
PLoS One; 2012; 7(2):e32204. PubMed ID: 22363817
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.
Kjøller L; Kanse SM; Kirkegaard T; Rodenburg KW; Rønne E; Goodman SL; Preissner KT; Ossowski L; Andreasen PA
Exp Cell Res; 1997 May; 232(2):420-9. PubMed ID: 9168821
[TBL] [Abstract][Full Text] [Related]
3. Dual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healing.
Maquerlot F; Galiacy S; Malo M; Guignabert C; Lawrence DA; d'Ortho MP; Barlovatz-Meimon G
Am J Pathol; 2006 Nov; 169(5):1624-32. PubMed ID: 17071586
[TBL] [Abstract][Full Text] [Related]
4. Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells.
Nakakuki T; Ito M; Iwasaki H; Kureishi Y; Okamoto R; Moriki N; Kongo M; Kato S; Yamada N; Isaka N; Nakano T
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2088-93. PubMed ID: 16123329
[TBL] [Abstract][Full Text] [Related]
5. ROCK1 and LIMK2 interact in spread but not blebbing cancer cells.
Shea KF; Wells CM; Garner AP; Jones GE
PLoS One; 2008; 3(10):e3398. PubMed ID: 18852895
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins.
Czekay RP; Aertgeerts K; Curriden SA; Loskutoff DJ
J Cell Biol; 2003 Mar; 160(5):781-91. PubMed ID: 12615913
[TBL] [Abstract][Full Text] [Related]
7. Membrane Tension Orchestrates Rear Retraction in Matrix-Directed Cell Migration.
Hetmanski JHR; de Belly H; Busnelli I; Waring T; Nair RV; Sokleva V; Dobre O; Cameron A; Gauthier N; Lamaze C; Swift J; Del Campo A; Starborg T; Zech T; Goetz JG; Paluch EK; Schwartz JM; Caswell PT
Dev Cell; 2019 Nov; 51(4):460-475.e10. PubMed ID: 31607653
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.
Whitley BR; Beaulieu LM; Carter JC; Church FC
Gynecol Oncol; 2007 Feb; 104(2):470-9. PubMed ID: 17070899
[TBL] [Abstract][Full Text] [Related]
9. ARHGEF10L contributes to liver tumorigenesis through RhoA-ROCK1 signaling and the epithelial-mesenchymal transition.
Tang J; Liu C; Xu B; Wang D; Ma Z; Chang X
Exp Cell Res; 2019 Jan; 374(1):46-68. PubMed ID: 30444969
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells.
Gilkes DM; Xiang L; Lee SJ; Chaturvedi P; Hubbi ME; Wirtz D; Semenza GL
Proc Natl Acad Sci U S A; 2014 Jan; 111(3):E384-93. PubMed ID: 24324133
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.
Samarakoon R; Higgins SP; Higgins CE; Higgins PJ
J Mol Cell Cardiol; 2008 Mar; 44(3):527-38. PubMed ID: 18255094
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling.
Stefansson S; McMahon GA; Petitclerc E; Lawrence DA
Curr Pharm Des; 2003; 9(19):1545-64. PubMed ID: 12871067
[TBL] [Abstract][Full Text] [Related]
13. Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells.
Eitaki M; Yamamori T; Meike S; Yasui H; Inanami O
BMC Cancer; 2012 Oct; 12():469. PubMed ID: 23057787
[TBL] [Abstract][Full Text] [Related]
14. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
[TBL] [Abstract][Full Text] [Related]
15. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.
Whitley BR; Church FC
Int J Oncol; 2005 Sep; 27(3):749-57. PubMed ID: 16077925
[TBL] [Abstract][Full Text] [Related]
16. Differential requirement for MEK/ERK and SMAD signaling in PAI-1 and CTGF expression in response to microtubule disruption.
Samarakoon R; Higgins CE; Higgins SP; Higgins PJ
Cell Signal; 2009 Jun; 21(6):986-95. PubMed ID: 19249354
[TBL] [Abstract][Full Text] [Related]
17. Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis.
Chillà A; Margheri F; Biagioni A; Del Rosso M; Fibbi G; Laurenzana A
J Exp Clin Cancer Res; 2018 Apr; 37(1):74. PubMed ID: 29615071
[TBL] [Abstract][Full Text] [Related]
18. RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells.
Ghasemi A; Hashemy SI; Aghaei M; Panjehpour M
Cell Signal; 2017 Apr; 32():104-114. PubMed ID: 28104444
[TBL] [Abstract][Full Text] [Related]
19. Matrix-bound plasminogen activator inhibitor type 1 inhibits the invasion of human monocytes into interstitial tissue.
Kirchheimer JC; Binder BR; Remold HG
J Immunol; 1990 Sep; 145(5):1518-22. PubMed ID: 1696600
[TBL] [Abstract][Full Text] [Related]
20. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
Yao J; Gao P; Xu Y; Li Z
Mol Med Rep; 2016 Sep; 14(3):2534-40. PubMed ID: 27432222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]